Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2026-01-01 @ 7:28 AM
Study NCT ID:
NCT06967961
Status:
RECRUITING
Last Update Posted:
2025-07-29
First Post:
2025-05-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Sponsor:
Institut Claudius Regaud
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Urothelial Carcinoma | View |
| None | Renal Cancer | View |
| None | Prostate Adenocarcinoma | View |
| None | Adenocarcinoma of Endometrium | View |
| None | Cutaneous Melanoma | View |
| None | Soft Tissue Sarcoma (STS) | View |
| None | Nonseminomatous Germ Cell Tumor | View |
| None | Seminomatous Germ Cell Tumor | View |
| None | Upper Aerodigestive Tract Carcinoma | View |
| None | Cervical Carcinoma | View |